These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9885204)

  • 41. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.
    Wislez M; Fleury-Feith J; Rabbe N; Moreau J; Cesari D; Milleron B; Mayaud C; Antoine M; Soler P; Cadranel J
    Am J Pathol; 2001 Oct; 159(4):1423-33. PubMed ID: 11583970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deleterious effects of mild hypothermia in septic rats are ameliorated by granulocyte colony-stimulating factor.
    Torossian A; Ruehlmann S; Middeke M; Sessler DI; Lorenz W; Wulf HF; Bauhofer A
    Anesthesiology; 2003 Nov; 99(5):1087-92. PubMed ID: 14576544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation.
    Rapoport AP; Abboud CN; DiPersio JF
    Blood Rev; 1992 Mar; 6(1):43-57. PubMed ID: 1375123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction.
    Presneill JJ; Harris T; Stewart AG; Cade JF; Wilson JW
    Am J Respir Crit Care Med; 2002 Jul; 166(2):138-43. PubMed ID: 12119223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Special therapeutic approaches for interrupting the cascade--from systemic inflammatory response syndrome to multiple organ failure].
    Bartels H; Zantl N; Holzmann B; Siewert JR
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():615-8. PubMed ID: 9931689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. G-CSF and GM-CSF for treating or preventing neonatal infections.
    Carr R; Modi N; Doré C
    Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colony-stimulating factors: clinical status.
    Gabrilove JL
    Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
    [No Abstract]   [Full Text] [Related]  

  • 49. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates.
    Bracho F; Goldman S; Cairo MS
    Curr Opin Hematol; 1998 May; 5(3):215-20. PubMed ID: 9664163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients.
    Ward NS; Casserly B; Ayala A
    Clin Chest Med; 2008 Dec; 29(4):617-25, viii. PubMed ID: 18954697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Two-Biomarker Model Predicts Mortality in the Critically Ill with Sepsis.
    Mikacenic C; Price BL; Harju-Baker S; O'Mahony DS; Robinson-Cohen C; Radella F; Hahn WO; Katz R; Christiani DC; Himmelfarb J; Liles WC; Wurfel MM
    Am J Respir Crit Care Med; 2017 Oct; 196(8):1004-1011. PubMed ID: 28418697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.
    Gillan ER; Christensen RD; Suen Y; Ellis R; van de Ven C; Cairo MS
    Blood; 1994 Sep; 84(5):1427-33. PubMed ID: 7520770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of tissue factor in systemic inflammatory response syndrome.
    Egorina EM; Sovershaev MA; Hansen JB
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):451-6. PubMed ID: 21597365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular IgM antibody in murine Escherichia coli sepsis.
    Hustinx W; Benaissa-Trouw B; Van Kessel K; Kuenen J; Tavares L; Kraaijeveld K; Verhoef J; Hoepelman A
    Eur J Clin Invest; 1997 Dec; 27(12):1044-8. PubMed ID: 9466134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclooxygenase inhibition in sepsis: is there life after death?
    Aronoff DM
    Mediators Inflamm; 2012; 2012():696897. PubMed ID: 22665954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis.
    Yekebas EF; Eisenberger CF; Ohnesorge H; Saalmüller A; Elsner HA; Engelhardt M; Gillesen A; Meins J; The M; Strate T; Busch C; Knoefel WT; Bloechle C; Izbicki JR
    Crit Care Med; 2001 Jul; 29(7):1423-30. PubMed ID: 11445702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Granulocyte colony-stimulating factor and neutrophil-related changes in local host defense during recovery from shock and intra-abdominal sepsis.
    Davis KA; Fabian TC; Ragsdale DN; Trenthem LL; Croce MA; Proctor KG
    Surgery; 1999 Aug; 126(2):305-13. PubMed ID: 10455899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The in vivo effect of recombinant human granulocyte-colony stimulating factor in neutropenic neonates with sepsis.
    Barak Y; Leibovitz E; Mogilner B; Juster-Reicher A; Amitay M; Ballin A; Koren A; Goebel M
    Eur J Pediatr; 1997 Aug; 156(8):643-6. PubMed ID: 9266199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.
    Zhang DE; Zhang P; Wang ND; Hetherington CJ; Darlington GJ; Tenen DG
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):569-74. PubMed ID: 9012825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.